Samy Babai
Arak University of Medical Sciences(IR)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Pharmacovigilance and Adverse Drug Reactions, Drug-Induced Adverse Reactions, Neuroblastoma Research and Treatments, Autoimmune Bullous Skin Diseases
Most-Cited Works
- → Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database(2016)177 cited
- → Safety data and withdrawal of hepatotoxic drugs(2018)110 cited
- → Pancreatitis associated with the use of GLP-1 analogs and DPP-4 inhibitors: a case/non-case study from the French Pharmacovigilance Database(2013)68 cited
- → Bullous pemphigoid induced by vildagliptin: a report of three cases(2014)61 cited
- → Immune check point inhibitors-induced hypophysitis: a retrospective analysis of the French Pharmacovigilance database(2019)59 cited
- → Occurrences and Outcomes of Immune Checkpoint Inhibitors-Induced Vitiligo in Cancer Patients: A Retrospective Cohort Study(2019)32 cited
- → Incretin-based drugs and intestinal obstruction: A pharmacovigilance study(2020)31 cited
- → Development of diffuse psoriasis with alopecia during treatment of Crohn's disease with infliximab(2010)25 cited
- → Thyroiditis and immune check point inhibitors: the post‐marketing experience using the French National Pharmacovigilance database(2018)23 cited
- → Comparison of Adverse Drug Reactions with Donepezil versus Memantine: Analysis of the French Pharmacovigilance Database(2010)17 cited